Benchmarks in Pancreatic Surgery

Patricia Sánchez‐Velázquez(University Hospital of Zurich), Xavier Muller(University Hospital of Zurich), Giuseppe Malleo(University of Verona), Joon Seong Park(Severance Hospital), Ho Kyoung Hwang(Severance Hospital), Niccolò Napoli(University of Pisa), Ammar A. Javed(Johns Hopkins University), Yosuke Inoue(The Cancer Institute Hospital), Nassiba Beghdadi(Hôpital Beaujon), Marit Kalisvaart(Queen Elizabeth Hospital Birmingham), Emanuel Vigia(Hospital Curry Cabral), Carrie D. Walsh(Thomas Jefferson University), Brendan P. Lovasik(Emory University), Juli Busquets(Bellvitge University Hospital), Chiara Maria Scandavini(Karolinska University Hospital), Fabien Robin(Université Claude Bernard Lyon 1), Hideyuki Yoshitomi(Chiba University Hospital), Tara M. Mackay(Amsterdam University Medical Centers), Olivier R. Busch(Amsterdam University Medical Centers), Hermien Hartog(Erasmus MC), Stefan Heinrich(Johannes Gutenberg University Mainz), Ana Gleisner(University of Colorado Denver), Julie Périnel(Hospices Civils de Lyon), Michael Passeri, Núria Lluís, Dimitri A. Raptis(University Hospital of Zurich), Christoph Tschuor(University Hospital of Zurich), Christian E. Oberkofler(University Hospital of Zurich), Michelle L. DeOliveira(University Hospital of Zurich), Henrik Petrowsky(University Hospital of Zurich), John B. Martinie, Horacio J. Asbun, Mustapha Adham(Hospices Civils de Lyon), Richard D. Schulick(University of Colorado Denver), Hauke Lang(Johannes Gutenberg University Mainz), Bas Groot Koerkamp(Erasmus MC), Marc G. Besselink(Amsterdam University Medical Centers), Ho‐Seong Han(Seoul National University Bundang Hospital), Masaru Miyazaki(Mita Hospital), Cristina R. Ferrone(Massachusetts General Hospital), Carlos Fernández-del Castillo(Massachusetts General Hospital), Keith D. Lillemoe(Massachusetts General Hospital), Laurent Sulpice(Université Claude Bernard Lyon 1), Karim Boudjéma(Université Claude Bernard Lyon 1), Marco Del Chiaro(Karolinska University Hospital), Joan Fabregat(Bellvitge University Hospital), David A. Kooby(Emory University), Peter J. Allen(Memorial Sloan Kettering Cancer Center), Harish Lavu(Thomas Jefferson University), Charles J. Yeo(Thomas Jefferson University), Eduardo Barroso(Hospital Curry Cabral), Keith Roberts(Queen Elizabeth Hospital Birmingham), Paolo Muiesan(Queen Elizabeth Hospital Birmingham), Alain Sauvanet(Hôpital Beaujon), Akio Saiura(The Cancer Institute Hospital), Christopher L. Wolfgang(Johns Hopkins University), John L. Cameron(Johns Hopkins University), Ugo Boggi(University of Pisa), Dong Sup Yoon(Severance Hospital), Claudio Bassi(University of Verona), Milo A. Puhan(University of Zurich), Pierre‐Alain Clavien(University Hospital of Zurich)
Annals of Surgery
March 14, 2019
Cited by 316Open Access
Full Text

Abstract

OBJECTIVE: To use the concept of benchmarking to establish robust and standardized outcome references after pancreatico-duodenectomy (PD). BACKGROUND: Best achievable results after PD are unknown. Consequently, outcome comparisons among different cohorts, centers or with novel surgical techniques remain speculative. METHODS: This multicenter study analyzes consecutive patients (2012-2015) undergoing PD in 23 international expert centers in pancreas surgery. Outcomes in patients without significant comorbidities and major vascular resection (benchmark cases) were analyzed to establish 20 outcome benchmarks for PD. These benchmarks were tested in a cohort with a poorer preoperative physical status (ASA class ≥3) and a cohort treated by minimally invasive approaches. RESULTS: Two thousand three hundred seventy-five (38%) low-risk cases out of a total of 6186 PDs were analyzed, disclosing low in-hospital mortality (≤1.6%) but high morbidity, with a 73% benchmark morbidity rate cumulated within 6 months following surgery. Benchmark cutoffs for pancreatic fistulas (B-C), severe complications (≥ grade 3), and failure-to-rescue rate were 19%, 30%, and 9%, respectively. The ASA ≥3 cohort showed comparable morbidity but a higher in hospital-mortality (3% vs 1.6%) and failure-to-rescue rate (16% vs 9%) than the benchmarks. The proportion of benchmark cases performed varied greatly across centers and continents for both open (9%-93%) and minimally invasive (11%-62%) PD. Centers operating mostly on complex PD cases disclosed better results than those with a majority of low-risk cases. CONCLUSION: The proposed outcome benchmarks for PD, established in a large-scale international patient cohort and tested in 2 different cohorts, may allow for meaningful comparisons between different patient cohorts, centers, countries, and surgical techniques.


Related Papers

No related papers found

Powered by citation graph analysis